Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies

Herpes zoster (HZ) is a debilitating vaccine-preventable disease. Impairment of cell-mediated immunity, as observed with aging and immunosuppressive disorders and therapies, increases risk. Recombinant zoster vaccine (RZV) is efficacious against HZ in adults aged ≥50 years in different settings, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwakingwe-Omari, Agnes, Lecrenier, Nicolas, Naficy, Abdi, Curran, Desmond, Posiuniene, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653762/
https://www.ncbi.nlm.nih.gov/pubmed/37965770
http://dx.doi.org/10.1080/21645515.2023.2278362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653762/
https://www.ncbi.nlm.nih.gov/pubmed/37965770
http://dx.doi.org/10.1080/21645515.2023.2278362

Ejemplares similares